Drug Shortage Report for RYMTI
| Report ID | 268087 |
| Drug Identification Number | 02530295 |
| Brand name | RYMTI |
| Common or Proper name | RYMTI |
| Company Name | LUPIN PHARMA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ETANERCEPT |
| Strength(s) | 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | Pre-filled syringes |
| ATC code | L04AB |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-09-29 |
| Actual start date | 2025-09-29 |
| Estimated end date | 2026-02-01 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-09-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 550-1111 RUE ST-CHARLES OUEST LONGUEUIL, QUEBEC CANADA J4K 5G4 |
| Company contact information | lupin@lsu3pl.ca (Customer service / Service à la clientèle) |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-09-30 | English | Compare |
| v3 | 2025-09-29 | French | Compare |
| v2 | 2025-09-29 | English | Compare |
| v1 | 2025-09-29 | English | Compare |
Showing 1 to 4 of 4